微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 39.61% | -5.16% | -2.12% | 91/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 40.47% | -5.4% | -0.74% | 91/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 40.77% | -3.24% | 0.5% | 89/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 40.57% | -3.23% | -2.87% | 90/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 41.77% | 2.05% | -2.37% | 86/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 42.78% | 2.54% | 1.52% | 88/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 42.14% | -0.62% | 0.51% | 89/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 41.93% | -0.18% | 2.44% | 91/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 40.93% | 6.96% | -1.9% | 89/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 41.72% | -5.17% | -1.61% | 96/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 42.4% | -0.56% | 0.95% | 90/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 42% | 1% | 9.77% | 92/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 38.26% | -8.98% | -13.03% | 96/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 44% | -0.3% | 3.17% | 88/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 42.64% | -0.69% | 2.55% | 87/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 41.58% | -4.14% | -1.07% | 93/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 42.04% | -2.68% | -4.74% | 82/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 44.13% | 2.5% | 2.77% | 96/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 42.94% | 3.43% | -1.02% | 86/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 43.38% | 5.65% | 0.44% | 94/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 43.19% | 0.4% | 0.32% | 80/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 43.05% | -3.72% | 3.7% | 102/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 41.51% | -6.14% | 1.11% | 74/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 41.06% | -3.87% | -4.55% | 92/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 43.02% | 3.25% | -3.79% | 57/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 44.71% | 0.68% | 1.1% | 82/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 44.23% | 4.07% | 3.55% | 44/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 42.71% | 3.67% | 2.52% | 57/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 41.67% | -2.77% | -6.18% | 35/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 44.41% | 0.61% | 4.49% | 73/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 42.5% | -5.36% | 3.16% | 32/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 41.2% | -5.21% | -3.85% | 40/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 42.85% | 5.54% | -2.92% | 32/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 44.14% | 10.33% | -1.71% | 69/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 44.91% | 14.64% | 3.31% | 26/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 43.47% | 12.41% | 7.06% | 38/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 40.6% | 6.74% | 1.49% | 32/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 40.01% | 0.96% | 2.13% | 60/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 39.17% | 2.12% | 1.31% | 30/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 38.67% | 0.2% | 1.66% | 36/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 38.04% | -5.04% | -4.01% | 24/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |